Literature DB >> 33669013

Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis.

Izabela Kokot1, Agnieszka Piwowar2, Marcin Jędryka3,4, Katarzyna Sołkiewicz1, Ewa Maria Kratz1.   

Abstract

Endometriosis is a gynecological disease, the pathogenesis of which seems to be directly associated with inflammatory processes. Serum concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL 40 and PRL, in comparison to the well-known CA 125 levels, were studied with the aim of identifying an additional noninvasive inflammatory marker or set of markers characteristic for endometriosis. The study group included 43 women with endometriosis (E), 35 women with benign gynecological disorders but without endometriosis (NE, non-endometriosis) as a comparative group, and a control group consisting of 18 healthy subjects (C). The serum concentrations of IL-1β, IL-6, hs-CRP, YKL-40, PRL and CA 125 were significantly higher in the E group (median values: 0.41 pg/mL, 2.42 pg/mL, 2.33 mg/L, 79.30 ng/mL, 21.88 ng/mL and 68.00 U/mL, respectively) than in the control group (median values: 0.21 pg/mL, 0.98 pg/mL, 0.52 mg/L, 49.77 ng/mL, 12.08 ng/mL and 12.20 U/mL respectively), with the significance of p = 0.011, p < 0.001, p = 0.028, p = 0.005, p < 0.001 and p < 0.001, respectively. The IgG concentrations were significantly lower in the endometriosis group (median value: 1061.21 mg/dL) as compared to healthy women (median value: 1210.50 mg/dL; p = 0.025). Significant differences in concentrations of IL-6 (p = 0.040), hs-CRP (p = 0.007) and CA 125 (p < 0.001) were observed in stage III vs. stage IV of endometriosis. Significantly higher concentrations of IL-6 (p = 0.010), hs-CRP (p = 0.037) and PRL (p < 0.001) were observed in the NE group vs. the control group. Only CA 125 concentrations were significantly higher in endometriosis patients as compared to the non-endometriosis group (p < 0.001). The proposed panel of inflammatory markers, especially IL-6, PRL and CA 125, may become a useful tool to identify women with advanced endometriosis who could qualify for treatment.

Entities:  

Keywords:  CA 125; advanced endometriosis; cytokines; diagnostics of endometriosis; serum parameters of inflammation

Mesh:

Substances:

Year:  2021        PMID: 33669013      PMCID: PMC7956504          DOI: 10.3390/ijms22052295

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  54 in total

Review 1.  Seven Hormonal Biomarkers for Diagnosing Endometriosis: Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy.

Authors:  Ya Gao; Minghui Shen; Xueni Ma; Jipin Li; Bo Wang; Jiancheng Wang; Jinhui Tian
Journal:  J Minim Invasive Gynecol       Date:  2019-04-06       Impact factor: 4.137

Review 2.  Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory.

Authors:  Xavier Bossuyt
Journal:  Autoimmun Rev       Date:  2009-02-05       Impact factor: 9.754

3.  Serum endometrial IgG antibodies and soluble CD23 concentrations in patients with endometriosis.

Authors:  O Odukoya; A Bansal; I Cooke
Journal:  Acta Obstet Gynecol Scand       Date:  1996-11       Impact factor: 3.636

4.  Differential effects of inhaled budesonide and oral prednisolone on serum immunoglobulin G and its subclasses in healthy adult volunteers.

Authors:  J Van Schoor; J H Toogood; R A Pauwels
Journal:  Clin Exp Allergy       Date:  1997-02       Impact factor: 5.018

Review 5.  Noninvasive diagnosis of endometriosis: Review of current peripheral blood and endometrial biomarkers.

Authors:  Dorien F O; Idhaliz Flores; Etienne Waelkens; Thomas D'Hooghe
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2018-04-13       Impact factor: 5.237

Review 6.  Prolactin and autoimmunity: The hormone as an inflammatory cytokine.

Authors:  Vânia Vieira Borba; Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-09-11       Impact factor: 4.690

7.  Measurement of hs-CRP is irrelevant to diagnose and stage endometriosis: prospective study of 834 patients.

Authors:  Thibault Thubert; Pietro Santulli; Louis Marcellin; Sophie Menard; Magatte M'Baye; Isabelle Streuli; Bruno Borghese; Dominique de Ziegler; Charles Chapron
Journal:  Am J Obstet Gynecol       Date:  2014-01-17       Impact factor: 8.661

Review 8.  Immunology of endometriosis.

Authors:  W Paul Dmowski; Donald P Braun
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-04       Impact factor: 5.237

9.  A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis.

Authors:  Alexandra Vodolazkaia; Xavier Bossuyt; Amelie Fassbender; Cleophas M Kyama; Christel Meuleman; Karen Peeraer; Carla Tomassetti; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

10.  How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis.

Authors:  Marco Aurelio Pinho Oliveira; Thiers Soares Raymundo; Leila Cristina Soares; Thiago Rodrigues Dantas Pereira; Alessandra Viviane Evangelista Demôro
Journal:  Biomed Res Int       Date:  2017-06-04       Impact factor: 3.411

View more
  9 in total

1.  miR-424-5p combined with miR-17-5p has high diagnostic efficacy for endometriosis.

Authors:  Chunli Lin; Saili Zeng; Miaojie Li
Journal:  Arch Gynecol Obstet       Date:  2022-04-03       Impact factor: 2.344

2.  ATR-IR Spectroscopy Application to Diagnostic Screening of Advanced Endometriosis.

Authors:  Izabela Kokot; Sylwester Mazurek; Agnieszka Piwowar; Roman Szostak; Marcin Jędryka; Ewa Maria Kratz
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

3.  A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations.

Authors:  Negin Mirzaei; Shahideh Jahanian Sadatmahalleh; Safoura Rouholamin; Malihe Nasiri
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.

Authors:  HuiFang Lei; ShuXia Xu; XiaoDan Mao; XiaoYing Chen; YaoJia Chen; XiaoQi Sun; PengMing Sun
Journal:  J Inflamm Res       Date:  2021-12-21

5.  The Coefficient of Variation of Red Blood Cell Distribution Width Combined with Cancer Antigen 125 Predicts Postoperative Overall Survival in Endometrial Cancer.

Authors:  Wenhui Zhong; Chunyu Zhou; Lufei Chen; Zhenna Wang; Hongxing Lin; Kunhai Wu; Sujiao Zhang
Journal:  Int J Gen Med       Date:  2021-09-21

6.  Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders.

Authors:  Jolanta Lis-Kuberka; Paulina Kubik; Agnieszka Chrobak; Jarosław Pająk; Anna Chełmońska-Soyta; Magdalena Orczyk-Pawiłowicz
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  O-Glycosylation Changes in Serum Immunoglobulin G Are Associated with Inflammation Development in Advanced Endometriosis.

Authors:  Katarzyna Sołkiewicz; Monika Kacperczyk; Hubert Krotkiewski; Marcin Jędryka; Ewa Maria Kratz
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

8.  Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis.

Authors:  Katarzyna Sołkiewicz; Hubert Krotkiewski; Marcin Jędryka; Ewa M Kratz
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

9.  The Alterations of Serum IgG Fucosylation as a Potential Additional New Diagnostic Marker in Advanced Endometriosis.

Authors:  Katarzyna Sołkiewicz; Hubert Krotkiewski; Marcin Jędryka; Andrzej Czekański; Ewa Maria Kratz
Journal:  J Inflamm Res       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.